The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and ...

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Meanwhile, scalp psoriasis tends to cause thicker ... Eczema is also linked to peanut allergies. If your baby has eczema, talk to your doctor about how and when to safely introduce them to ...

Psoriasis and dandruff can both trigger itching and flaky scalp skin. Psoriasis is a chronic autoimmune disorder that can cause thick patches of skin known as plaques on the scalp to become dry ...

The FDA approved a supplemental new drug application for roflumilast topical foam 0.3% for the treatment of plaque psoriasis ...

For scalp psoriasis or seborrheic dermatitis, a dermatologist typically recommends using a salicylic acid shampoo 2 to 3 ...

A total of 432 patients (56.3% women) aged 12 and older with psoriasis on the scalp and body were randomly assigned to two groups, one of which used roflumilast foam 0.3% once a day for eight ...

Two of the most common issues are scalp psoriasis and dandruff. While both conditions may seem similar due to their shared symptom of flaky skin, they are fundamentally different in their causes ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients ...